Metformin inhibits cardiometabolic syndrome associated cognitive deficits in high fat diet rats
- PMID: 36404813
- PMCID: PMC9672285
- DOI: 10.1007/s40200-022-01074-4
Metformin inhibits cardiometabolic syndrome associated cognitive deficits in high fat diet rats
Erratum in
-
Correction to: Metformin inhibits cardiometabolic syndrome associated cognitive deficits in high fat diet rats.J Diabetes Metab Disord. 2023 Jul 24;22(2):1813. doi: 10.1007/s40200-023-01229-x. eCollection 2023 Dec. J Diabetes Metab Disord. 2023. PMID: 37969918 Free PMC article.
Abstract
Objectives: Glucose intolerance and insulin resistance are hallmarks of metabolic syndrome and lead to Alzheimer's disease (AD). The purpose of this study is to elucidate the neuroprotective effect of metformin through insulin regulation with cardiometabolic and neurotransmitter metabolic enzyme regulation in high-fat, high-sucrose diet and streptozotocin (HFHS-STZ)-induced rats.
Methods: Male Wistar rats were treated with metformin (180 mg/kg and 360 mg/kg). STZ (35 mg/kg i.p.) injection was performed on the 14th day of 42 days of HFHS diet treatment. Brain neurotransmitter metabolic enzymes (acetylcholinesterase and monoamine oxidase) were determined along with sodium-potassium ATPase (Na+K+-ATPase). Plasma lipids and homeostasis model assessment of insulin resistance (HOMA-IR) was performed. Mean arterial blood pressure, heart rate and electrocardiogram (QT, QTc and RR intervals) were analysed with PowerLab.
Results: Metformin treatment significantly (p < 0.001) reduced the HOMA-IR index and decreased neurotransmitter metabolic enzymes such as AChE and MAO (p < 0.01 and p < 0.05). The lipid profile was significantly (p < 0.001) controlled with cardiometabolic functions.
Conclusions: Our investigation revealed that metformin has a remarkable role in regulating brain insulin, vascular system with monoaminergic metabolic enzymes and enhancing synaptic plasticity. Metformin may be a selective early therapeutic agent in metabolic syndrome associated with cognitive decline.
Keywords: Alzheimer’s disease; Cognitive dysfunction; Insulin resistance; Metabolic cardiovascular syndrome; Metformin; Neuroprotection.
© The Author(s), under exclusive licence to Tehran University of Medical Sciences 2022.
Conflict of interest statement
Declaration of conflict of interestThe corresponding author states that there is no conflict of interest among all authors.
Figures
Similar articles
-
A comparison of the effects of Stevia extract and metformin on metabolic syndrome indices in rats fed with a high-fat, high-sucrose diet.J Food Biochem. 2020 Aug;44(8):e13242. doi: 10.1111/jfbc.13242. Epub 2020 Jun 1. J Food Biochem. 2020. PMID: 32478426
-
Neuroprotective effect of Liuwei Dihuang decoction on cognition deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat.J Ethnopharmacol. 2013 Oct 28;150(1):371-81. doi: 10.1016/j.jep.2013.09.003. Epub 2013 Sep 14. J Ethnopharmacol. 2013. Retraction in: J Ethnopharmacol. 2022 Jun 12;291:115176. doi: 10.1016/j.jep.2022.115176. PMID: 24041458 Retracted.
-
Intranasal metformin treatment ameliorates cognitive functions via insulin signaling pathway in ICV-STZ-induced mice model of Alzheimer's disease.Life Sci. 2022 Jun 15;299:120538. doi: 10.1016/j.lfs.2022.120538. Epub 2022 Apr 6. Life Sci. 2022. PMID: 35395244
-
Construction of the experimental rat model of gestational diabetes.PLoS One. 2022 Sep 15;17(9):e0273703. doi: 10.1371/journal.pone.0273703. eCollection 2022. PLoS One. 2022. PMID: 36107823 Free PMC article.
-
Rosa canina L. improves learning and memory-associated cognitive impairment by regulating glucose levels and reducing hippocampal insulin resistance in high-fat diet/streptozotocin-induced diabetic rats.J Ethnopharmacol. 2023 Sep 15;313:116541. doi: 10.1016/j.jep.2023.116541. Epub 2023 Apr 23. J Ethnopharmacol. 2023. PMID: 37088237
Cited by
-
Oxidative Stress Markers and Na,K-ATPase Enzyme Kinetics Are Altered in the Cerebellum of Zucker Diabetic Fatty fa/fa Rats: A Comparison with Lean fa/+ and Wistar Rats.Biology (Basel). 2024 Sep 25;13(10):759. doi: 10.3390/biology13100759. Biology (Basel). 2024. PMID: 39452068 Free PMC article.
-
Metformin Mitigates Trimethyltin-Induced Cognition Impairment and Hippocampal Neurodegeneration.Cell Mol Neurobiol. 2024 Oct 23;44(1):70. doi: 10.1007/s10571-024-01502-4. Cell Mol Neurobiol. 2024. PMID: 39441380 Free PMC article.
-
Cognitive Impairment and Synaptic Dysfunction in Cardiovascular Disorders: The New Frontiers of the Heart-Brain Axis.Biomedicines. 2024 Oct 18;12(10):2387. doi: 10.3390/biomedicines12102387. Biomedicines. 2024. PMID: 39457698 Free PMC article. Review.
References
-
- Yeh SH-H, Shie F-S, Liu H-K, Yao H-H, Kao P-C, Lee Y-H, et al. A high-sucrose diet aggravates Alzheimer’s disease pathology, attenuates hypothalamic leptin signaling, and impairs food-anticipatory activity in APPswe/PS1dE9 mice. Neurobiol Aging. 2020;90:60–74. doi: 10.1016/j.neurobiolaging.2019.11.018. - DOI - PubMed
LinkOut - more resources
Full Text Sources